Digestive and Liver Disease

Journal Information
ISSN / EISSN : 15908658 / 18783562
Current Publisher: Elsevier BV (10.1016)
Total articles ≅ 15,994
Current Coverage
SCOPUS
PUBMED
MEDLINE
MEDICUS
SCIE
Archived in
SHERPA/ROMEO
Filter:

Latest articles in this journal

Kyung Hyun Kim, Dong Jin Joo, Yong-Ho Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Published: 5 August 2020
Digestive and Liver Disease; doi:10.1016/j.dld.2020.07.004

The publisher has not yet granted permission to display this abstract.
Published: 1 August 2020
Digestive and Liver Disease, Volume 52; doi:10.1016/s1590-8658(20)30349-2

Mario Schettino, Simone Saibeni, Cristina Bezzio, Germana De Nucci, Gianpiero Manes
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 840-841; doi:10.1016/j.dld.2020.06.017

Philippe L. Pereira, Dirk Arnold, Thierry De Baère, Fernando Gomez, Thomas Helmberger, Roberto Iezzi, Geert Maleux, Hans Prenen, Bruno Sangro, Anders Nordlund, et al.
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 857-861; doi:10.1016/j.dld.2020.05.051

Abstract:
BackgroundAbout 70–80% of patients with colorectal liver metastases appear as ineligible for a curative treatment approach. Transarterial chemoembolisation (TACE) using irinotecan-eluting beads has emerged as a promising treatment option in cases with irresectable liver metastases. Despite being in clinical practice for years, little is known about the treatment characteristics and outcomes when used as per routine hospital practice.MethodsPatients with hepatic metastases from colorectal cancer origin, admitted to contributing centres to receive TACE with drug-eluting LifePearl® Microspheres loaded with irinotecan, as part of their standard care, will be consecutively added to the registry. Data will be collected until the end of study, loss to follow-up or death. Primary endpoint is the characterisation of the treatment usage at the selected sites in Europe. Secondary endpoints include outcome parameters, safety and toxicity, as well as quality of life.Conclusion and AIMSThis multicentre, international, prospective observational study conducted in European centres plans to collect real-life data. This data will form an evidence-base from which conclusions can be drawn on how to improve patient selection and optimise treatment protocols when treating with TACE using irinotecan-eluting microspheres.Trial registrationNCT03086096
Giulia Tripodi, Emanuele Dilaghi, Silvia Fanella, Vito Domenico Corleto, Emilio Di Giulio, Endoscopy prioritization group
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 829-830; doi:10.1016/j.dld.2020.06.032

The publisher has not yet granted permission to display this abstract.
Macarena Ortiz, Sandra A. Soto-Alarcón, Paula Orellana, Alejandra Espinosa, Cristian Campos, Sandra López-Arana, Miguel A. Rincón, Paola Illesca, Rodrigo Valenzuela, Luis A. Videla
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 895-904; doi:10.1016/j.dld.2020.04.019

The publisher has not yet granted permission to display this abstract.
Roberto Grassia, Sophie Testa, Annalisa De Silvestri, Andrea Drago, Fabrizio Cereatti, Clara Benedetta Conti
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 816-818; doi:10.1016/j.dld.2020.06.013

The publisher has not yet granted permission to display this abstract.
Claire Gouriou, Marion Chambaz, Alain Ropert, Guillaume Bouguen, Aurélien Venara, Guillaume Meurette, Laurent Siproudhis, Charlène Brochard
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 885-888; doi:10.1016/j.dld.2020.05.013

The publisher has not yet granted permission to display this abstract.
Vincenzo Savarino, Elisa Marabotto, Manuele Furnari, Fabiana Zingone, Patrizia Zentilin, Edoardo Savarino
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 842-852; doi:10.1016/j.dld.2020.04.020

The publisher has not yet granted permission to display this abstract.
Engy A. Mogahed, Haytham Ghita, Mona S. El-Raziky, Seham A. El-Sherbini, Doaa Meshref, Hanaa El-Karaksy
Published: 1 August 2020
Digestive and Liver Disease, Volume 52, pp 889-894; doi:10.1016/j.dld.2020.04.035

The publisher has not yet granted permission to display this abstract.
Back to Top Top